MGC Pharmaceuticals is a publicly traded (ASX: MXC) BioPharma...

MGC Pharmaceuticals is a publicly traded (ASX: MXC) BioPharma company with a focus on Phytocannabinoid Medications. MGC Pharma has created a seamless, highly-supervised supply chain, for developing Phytocannabinoid medications from seed to sale, with global operations providing proprietary Phytocannabinoid formulations to companies, consumers, researchers and patients worldwide.MGC Pharma’s medications (currently in clinical trials) for treatment areas such as Neurology, Oncology and Auto-Immune (Anti-Inflammatory), all emerge from this pipeline, with the list continuing to grow as more research materializes. With research activities in various fields in Europe, Australia and Israel, MGC Pharma intends to impact global health and wellness via the judicious use of Phytocannabinoids across multiple markets.

Pharma_ProductCatalogue.pdf